P
Peptide Partners
Vendor-Supplied Policies
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Ipamorelin | A | 7 | 9.9 | 9.4 | 10.0 | 23 Oct 2025 |
| BPC-157 | A | 7 | 8.0 | 6.9 | 10.0 | 23 Oct 2025 |
| Retatrutide | A | 16 | 8.8 | 6.7 | 10.0 | 17 Jul 2025 |
| TB-500 | A | 7 | 8.2 | 6.5 | 10.0 | 30 Jan 2026 |
| Tesamorelin | B | 11 | 7.8 | 5.3 | 10.0 | 30 Jan 2026 |
| CJC-1295 | C | 9 | 6.7 | 4.3 | 9.4 | 4 Nov 2025 |
| Tirzepatide | C | 6 | 8.2 | 4.2 | 9.8 | 11 Jun 2025 |
| 5-amino-1MQ | X | 1 | 7.6 | 7.6 | 7.6 | 28 Mar 2025 |
| Andarine (S-4) Raw | A | 3 | 7.3 | 5.6 | 8.9 | 17 May 2026 |
| ARA-290 | A | 2 | 7.2 | 6.9 | 7.5 | 21 May 2026 |
| Aromasin (Exemestane) | A | 2 | 8.2 | 7.0 | 9.5 | 20 May 2026 |
| Blend 300 (TRA/Mast P/Test P) | A | 4 | 8.6 | 6.6 | 9.9 | 25 May 2026 |
| BPC157 5mg + TB500 5mg Blend | A | 2 | 8.3 | 6.7 | 10.0 | 20 May 2026 |
| Cabergoline | A | 6 | 8.3 | 6.3 | 9.9 | 17 May 2026 |
| Cartalax | A | 2 | 9.6 | 9.2 | 10.0 | 21 May 2026 |
| Cerebrolysin | A | 4 | 7.8 | 6.8 | 10.0 | 17 May 2026 |
| Clenbuterol | A | 3 | 8.4 | 7.5 | 9.7 | 25 May 2026 |
| Clomid | A | 3 | 8.4 | 6.9 | 9.8 | 19 Jan 2026 |
| DHB (1-Test Cyp) Oral | X | 1 | 7.7 | 7.7 | 7.7 | 13 Jun 2025 |
| DNP | A | 5 | 8.0 | 6.5 | 9.3 | 25 May 2026 |
| Drostanolone Enanthate (Mast E) Raw | A | 4 | 8.8 | 6.3 | 10.0 | 23 May 2026 |
| EPO | A | 5 | 9.2 | 7.7 | 10.0 | 20 May 2026 |
| Hexarelin | A | 3 | 7.9 | 6.3 | 10.0 | 19 Jan 2026 |
| HMG | A | 4 | 8.2 | 6.7 | 10.0 | 23 May 2026 |
| Ivermectin | A | 6 | 8.5 | 6.0 | 10.0 | 21 May 2026 |
| KPV Oral | A | 3 | 9.3 | 8.2 | 10.0 | 26 Jan 2026 |
| KPV | A | 6 | 8.1 | 4.8 | 10.0 | 19 Jan 2026 |
| LGD-4033 (Ligandrol) | X | 1 | 8.5 | 8.5 | 8.5 | 2 Jul 2025 |
| Lipo-C FAT BLASTER | A | 5 | 7.2 | 5.2 | 8.8 | 21 May 2026 |
| Minoxidil Oral | A | 6 | 7.8 | 5.6 | 10.0 | 24 May 2026 |
| MT-1 | A | 2 | 6.9 | 4.9 | 8.9 | 20 May 2026 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | A | 5 | 8.8 | 7.0 | 10.0 | 24 May 2026 |
| NAD+ | A | 3 | 9.1 | 7.2 | 10.0 | 23 May 2026 |
| PE 22-28 | A | 2 | 6.8 | 6.2 | 7.3 | 24 May 2026 |
| PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | A | 5 | 7.8 | 6.4 | 9.6 | 25 May 2026 |
| Primobolan Oral (Methenolone Acetate) | A | 5 | 7.5 | 6.7 | 8.1 | 17 May 2026 |
| PTD-DBM | A | 6 | 7.8 | 4.7 | 9.5 | 23 May 2026 |
| Retatrutide 30mg Pen Kit | A | 3 | 7.7 | 7.3 | 8.3 | 21 May 2026 |
| Superdrol | A | 6 | 7.7 | 6.5 | 10.0 | 24 May 2026 |
| Tadalafil Raw | X | 1 | 8.3 | 8.3 | 8.3 | 28 Mar 2025 |
| Telmisartan | A | 3 | 8.8 | 8.2 | 10.0 | 21 May 2026 |
| Tesofensine | X | 1 | 9.2 | 9.2 | 9.2 | 21 May 2025 |
| Test Suspension | A | 2 | 9.4 | 8.9 | 10.0 | 23 May 2026 |
| Testosterone Cypionate Raw | A | 6 | 8.8 | 7.2 | 10.0 | 23 May 2026 |
| Thymosin Alpha-1 | A | 5 | 8.2 | 7.6 | 9.0 | 20 May 2026 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | Telmisartan | 8.1 | 20mg | 19.8mg | -0.9% | 98.58% | Lab B |
| 24 May 2026 | Clomid | 8.4 | 25mg | 21.9mg | -12.3% | 97.46% | Lab A |
| 24 May 2026 | Testosterone Cypionate Raw | 8.9 | 5g | 4.4g | -12.4% | 95.03% | Lab B |
| 24 May 2026 | BPC-157 | 7.2 | 10mg | 10.7mg | +7.0% | BP202512 | |
| 24 May 2026 | TB-500 | Thymosin Beta-4 | 7.1 | 10mg | 10.7mg | +7.0% | TB202601 |
| 24 May 2026 | 5-amino-1MQ | 7.6 | 2mg | 2.3mg | +12.8% | 96.18% | Lab A |
| 24 May 2026 | Andarine (S-4) Raw | 7.2 | 100g | 89.3g | -10.7% | 97.71% | Lab A |
| 24 May 2026 | EPO | 10.0 | 5mg | 4.4mg | -12.8% | 96.46% | Lab F |
| 24 May 2026 | Ivermectin | 9.8 | 100mg | 118.2mg | +18.2% | 98.99% | Lab B |
| 24 May 2026 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 8.7 | 100g | 90.8g | -9.2% | 99.96% | Lab E |
| 24 May 2026 | PTD-DBM | 9.1 | 30mg | 31.5mg | +5.0% | 99.26% | Lab B |
| 24 May 2026 | Minoxidil Oral | 8.0 | 100mg | 90.1mg | -9.9% | 98.98% | Lab F |
| 24 May 2026 | Minoxidil Oral | 6.8 | 100mg | 101.7mg | +1.7% | 96.68% | Lab G |
| 24 May 2026 | Testosterone Cypionate Raw | 8.6 | 5g | 4.9g | -2.9% | 95.33% | Lab B |
| 24 May 2026 | Retatrutide | 9.3 | 24mg | 22.3mg | -7.1% | RT202602 | |
| 24 May 2026 | Blend 300 (TRA/Mast P/Test P) | 8.3 | 200mg/ml | 200.1mg/ml | +0.1% | 97.51% | Lab G |
| 24 May 2026 | BPC157 5mg + TB500 5mg Blend | 10.0 | 10mg | 10.9mg | +8.8% | 95.29% | Lab D |
| 24 May 2026 | Cerebrolysin | 7.1 | 10mg | 9.3mg | -7.2% | 95.65% | Lab B |
| 24 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 8.0 | 50mg | 42.9mg | -14.2% | 97.43% | Lab B |
| 24 May 2026 | Retatrutide | 6.7 | 30mg | 23.9mg | -20.3% | RP260130 | |
| 24 May 2026 | KPV | 6.2 | 15mg | 12.8mg | -14.9% | 99.45% | Lab C |
| 24 May 2026 | NAD+ | 8.4 | 50mg | 53.3mg | +6.6% | 96.80% | Lab G |
| 24 May 2026 | NAD+ | 8.6 | 15mg | 13.6mg | -9.0% | 96.95% | Lab F |
| 24 May 2026 | Primobolan Oral (Methenolone Acetate) | 7.3 | 20mg | 23.8mg | +18.8% | 99.11% | Lab G |
| 24 May 2026 | Tadalafil Raw | 9.7 | 100g | 106.7g | +6.7% | 95.51% | Lab A |
| 23 May 2026 | Clenbuterol | 7.3 | 20mg | 21.4mg | +6.8% | 96.65% | Lab G |
| 23 May 2026 | Lipo-C FAT BLASTER | 6.3 | 300mg/ml | 356.8mg/ml | +18.9% | 95.88% | Lab E |
| 23 May 2026 | Cabergoline | 8.6 | 20mg | 18.0mg | -10.2% | 99.48% | Lab B |
| 23 May 2026 | DNP | 8.3 | 25mg | 26.8mg | +7.3% | 96.66% | Lab G |
| 23 May 2026 | Ivermectin | 8.3 | 100mg | 96.2mg | -3.8% | 97.41% | Lab F |
| 23 May 2026 | KPV Oral | 9.7 | 50mg | 56.0mg | +11.9% | 99.81% | Lab B |
| 23 May 2026 | Minoxidil Oral | 8.5 | 10mg | 10.1mg | +1.3% | 96.93% | Lab B |
| 23 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 9.9 | 20mg | 19.6mg | -2.1% | 99.05% | Lab E |
| 23 May 2026 | PE 22-28 | 7.6 | 2mg | 2.5mg | +23.3% | 99.94% | Lab G |
| 23 May 2026 | Superdrol | 9.1 | 20mg | 20.8mg | +3.8% | 99.37% | Lab C |
| 23 May 2026 | Thymosin Alpha-1 | 9.9 | 10mg | 12.3mg | +23.4% | 95.81% | Lab F |
| 22 May 2026 | Retatrutide | 9.4 | 24mg | 23.3mg | -2.9% | RT202602 | |
| 21 May 2026 | Tesamorelin | 6.7 | 10mg | 12.8mg | +28.0% | TES202601 | |
| 21 May 2026 | Blend 300 (TRA/Mast P/Test P) | 7.3 | 200mg/ml | 222.7mg/ml | +11.3% | 95.89% | Lab F |
| 21 May 2026 | HMG | 8.3 | 5mg | 4.4mg | -11.9% | 95.38% | Lab A |
| 21 May 2026 | Tesamorelin | 5.3 | 10mg | 12mg | +20.0% | TES202601 | |
| 21 May 2026 | DHB (1-Test Cyp) Oral | 6.9 | 20mg | 22.1mg | +10.4% | 99.69% | Lab C |
| 21 May 2026 | KPV | 8.8 | 30mg | 30.3mg | +1.1% | 95.23% | Lab F |
| 21 May 2026 | LGD-4033 (Ligandrol) | 9.4 | 25mg | 28.2mg | +13.0% | 98.31% | Lab A |
| 21 May 2026 | PTD-DBM | 5.6 | 15mg | 18.7mg | +24.9% | 95.75% | Lab A |
| 21 May 2026 | Telmisartan | 8.5 | 50mg | 52.5mg | +4.9% | 98.23% | Lab D |
| 20 May 2026 | Cabergoline | 8.7 | 10mg | 11.6mg | +16.3% | 98.33% | Lab C |
| 20 May 2026 | HMG | 7.9 | 30mg | 33.4mg | +11.2% | 98.09% | Lab D |
| 20 May 2026 | Retatrutide 30mg Pen Kit | 7.9 | 20mg | 20.6mg | +3.2% | 95.82% | Lab A |
| 20 May 2026 | Test Suspension | 8.6 | 250mg/ml | 264.5mg/ml | +5.8% | 98.71% | Lab B |
| 20 May 2026 | Thymosin Alpha-1 | 7.4 | 50mg | 44.3mg | -11.5% | 96.17% | Lab A |
| 19 May 2026 | BPC157 5mg + TB500 5mg Blend | 8.4 | 20mg | 21.9mg | +9.3% | 99.56% | Lab C |
| 19 May 2026 | Cerebrolysin | 7.0 | 20mg | 18.5mg | -7.5% | 97.85% | Lab D |
| 19 May 2026 | MT-1 | 7.9 | 50mg | 57.4mg | +14.7% | 97.84% | Lab D |
| 19 May 2026 | Testosterone Cypionate Raw | 9.4 | 10g | 9.0g | -9.9% | 99.74% | Lab D |
| 17 May 2026 | Drostanolone Enanthate (Mast E) Raw | 7.1 | 5g | 6.2g | +24.0% | 96.37% | Lab B |
| 17 May 2026 | NAD+ | 7.7 | 10mg | 10.0mg | -0.1% | 96.17% | Lab C |
| 17 May 2026 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 7.2 | 5g | 5.1g | +2.4% | 97.32% | Lab C |
| 17 May 2026 | Superdrol | 9.8 | 10mg | 9.6mg | -4.0% | 99.69% | Lab E |
| 17 May 2026 | Testosterone Cypionate Raw | 9.2 | 500g | 615.9g | +23.2% | 95.74% | Lab A |
| 29 Jan 2026 | Clenbuterol | 8.2 | 100mg | 99.3mg | -0.7% | 96.68% | Lab C |
| 29 Jan 2026 | Retatrutide 30mg Pen Kit | 9.5 | 30mg | 30.7mg | +2.5% | 96.90% | Lab D |
| 26 Jan 2026 | Andarine (S-4) Raw | 5.4 | 1g | 1.0g | +1.7% | 99.55% | Lab E |
| 26 Jan 2026 | Aromasin (Exemestane) | 7.4 | 25mg | 29.8mg | +19.2% | 95.04% | Lab B |
| 26 Jan 2026 | MT-1 | 6.4 | 5mg | 4.8mg | -4.7% | 99.09% | Lab A |
| 26 Jan 2026 | PTD-DBM | 9.8 | 15mg | 18.7mg | +25.0% | 97.12% | Lab B |
| 19 Jan 2026 | Clenbuterol | 9.9 | 100mg | 110.2mg | +10.2% | 97.92% | Lab D |
| 19 Jan 2026 | EPO | 8.1 | 10mg | 10.2mg | +1.8% | 98.21% | Lab G |
| 19 Jan 2026 | KPV | 8.8 | 50mg | 56.0mg | +12.0% | 99.36% | Lab C |
| 19 Jan 2026 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 7.0 | 10g | 12.4g | +24.2% | 97.86% | Lab D |
| 19 Jan 2026 | Thymosin Alpha-1 | 9.7 | 50mg | 45.8mg | -8.4% | 98.02% | Lab D |
| 9 Jan 2026 | Cartalax | 9.2 | 10mg | 8.8mg | -12.1% | 96.72% | Lab E |
| 9 Jan 2026 | Drostanolone Enanthate (Mast E) Raw | 9.1 | 100g | 92.2g | -7.8% | 99.77% | Lab F |
| 9 Jan 2026 | EPO | 8.3 | 50mg | 55.6mg | +11.1% | 96.02% | Lab C |
| 9 Jan 2026 | Ivermectin | 10.0 | 100mg | 87.1mg | -12.9% | 98.53% | Lab D |
| 9 Jan 2026 | KPV | 8.6 | 30mg | 36.9mg | +23.0% | 95.60% | Lab A |
| 9 Jan 2026 | Lipo-C FAT BLASTER | 9.1 | 300mg/ml | 260.4mg/ml | -13.2% | 97.34% | Lab C |
| 9 Jan 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 10.0 | 5mg | 5.8mg | +15.7% | 95.56% | Lab F |
| 9 Jan 2026 | PTD-DBM | 8.2 | 30mg | 32.5mg | +8.3% | 99.58% | Lab D |
| 9 Jan 2026 | Telmisartan | 10.0 | 100mg | 102.6mg | +2.6% | 97.42% | Lab G |
| 7 Jan 2026 | Drostanolone Enanthate (Mast E) Raw | 9.2 | 500g | 477.3g | -4.5% | 97.12% | Lab G |
| 7 Jan 2026 | EPO | 9.0 | 30mg | 29.2mg | -2.7% | 97.66% | Lab E |
| 7 Jan 2026 | Lipo-C FAT BLASTER | 6.2 | 100mg/ml | 111.4mg/ml | +11.4% | 95.51% | Lab D |
| 6 Jan 2026 | DNP | 7.1 | 50mg | 52.8mg | +5.7% | 97.99% | Lab B |
| 6 Jan 2026 | DNP | 7.8 | 10mg | 10.9mg | +8.8% | 95.52% | Lab C |
| 6 Jan 2026 | Ivermectin | 9.1 | 10mg | 9.9mg | -0.8% | 97.47% | Lab D |
| 6 Jan 2026 | Primobolan Oral (Methenolone Acetate) | 8.9 | 20mg | 23.1mg | +15.3% | 97.30% | Lab F |
| 6 Jan 2026 | PTD-DBM | 6.6 | 10mg | 10.2mg | +1.8% | 97.42% | Lab F |
| 29 Dec 2025 | Cartalax | 10.0 | 5mg | 5.0mg | +0.8% | 99.11% | Lab F |
| 29 Dec 2025 | Minoxidil Oral | 8.1 | 100mg | 103.1mg | +3.1% | 99.24% | Lab E |
| 29 Dec 2025 | Superdrol | 9.9 | 25mg | 25.3mg | +1.3% | 95.36% | Lab C |
| 12 Dec 2025 | Andarine (S-4) Raw | 6.4 | 100g | 98.1g | -1.9% | 95.15% | Lab E |
| 12 Dec 2025 | HMG | 9.7 | 5mg | 5.1mg | +3.0% | 96.75% | Lab G |
| 12 Dec 2025 | KPV | 9.1 | 50mg | 58.6mg | +17.2% | 96.37% | Lab D |
| 12 Dec 2025 | Minoxidil Oral | 8.7 | 100mg | 120.6mg | +20.6% | 97.13% | Lab G |
| 12 Dec 2025 | Thymosin Alpha-1 | 8.1 | 5mg | 4.4mg | -11.9% | 97.80% | Lab F |
| 5 Dec 2025 | Blend 300 (TRA/Mast P/Test P) | 6.6 | 250mg/ml | 243.4mg/ml | -2.7% | 97.58% | Lab B |
| 5 Dec 2025 | Cabergoline | 8.2 | 100mg | 106.8mg | +6.8% | 97.68% | Lab C |
| 5 Dec 2025 | Cerebrolysin | 9.1 | 15mg | 14.8mg | -1.4% | 95.80% | Lab C |
| 23 Nov 2025 | ARA-290 | 8.0 | 30mg | 32.8mg | +9.3% | 95.71% | Lab A |
| 23 Nov 2025 | Blend 300 (TRA/Mast P/Test P) | 9.9 | 250mg/ml | 280.8mg/ml | +12.3% | 95.59% | Lab C |
| 23 Nov 2025 | Drostanolone Enanthate (Mast E) Raw | 10.0 | 1g | 1.1g | +5.6% | 97.73% | Lab C |
| 23 Nov 2025 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 8.0 | 100g | 111.8g | +11.8% | 97.38% | Lab C |
| 23 Nov 2025 | Retatrutide 30mg Pen Kit | 6.3 | 20mg | 22.8mg | +14.1% | 95.39% | Lab B |
| 23 Nov 2025 | Superdrol | 9.2 | 25mg | 29.8mg | +19.1% | 98.82% | Lab E |
| 17 Nov 2025 | Cerebrolysin | 7.2 | 20mg | 21.5mg | +7.4% | 98.66% | Lab C |
| 17 Nov 2025 | Clomid | 8.3 | 20mg | 23.1mg | +15.6% | 96.86% | Lab C |
| 17 Nov 2025 | DNP | 6.8 | 100mg | 108.0mg | +8.0% | 97.58% | Lab F |
| 17 Nov 2025 | EPO | 7.4 | 5mg | 4.4mg | -11.8% | 99.96% | Lab E |
| 17 Nov 2025 | Hexarelin | 8.8 | 20mg | 22.7mg | +13.7% | 95.97% | Lab D |
| 17 Nov 2025 | Hexarelin | 8.8 | 10mg | 9.3mg | -6.7% | 95.13% | Lab E |
| 17 Nov 2025 | Lipo-C FAT BLASTER | 6.4 | 100mg/ml | 92.6mg/ml | -7.4% | 98.73% | Lab A |
| 17 Nov 2025 | PE 22-28 | 9.9 | 10mg | 8.9mg | -11.0% | 95.79% | Lab E |
| 17 Nov 2025 | Tesofensine | 8.7 | 10mg | 9.4mg | -5.6% | 95.73% | Lab C |
| 14 Nov 2025 | Cabergoline | 7.8 | 20mg | 21.3mg | +6.5% | 99.24% | Lab D |
| 14 Nov 2025 | Cabergoline | 6.9 | 25mg | 26.8mg | +7.4% | 96.41% | Lab G |
| 14 Nov 2025 | DNP | 8.1 | 50mg | 48.5mg | -3.1% | 97.09% | Lab C |
| 14 Nov 2025 | Primobolan Oral (Methenolone Acetate) | 8.1 | 100mg | 89.9mg | -10.1% | 96.31% | Lab D |
| 14 Nov 2025 | PTD-DBM | 7.6 | 20mg | 22.7mg | +13.5% | 98.72% | Lab G |
| 14 Nov 2025 | Superdrol | 7.2 | 25mg | 26.9mg | +7.7% | 97.05% | Lab F |
| 5 Nov 2025 | Aromasin (Exemestane) | 10.0 | 100mg | 102.7mg | +2.7% | 96.41% | Lab C |
| 5 Nov 2025 | Hexarelin | 6.0 | 50mg | 50.4mg | +0.7% | 96.65% | Lab B |
| 5 Nov 2025 | Ivermectin | 6.6 | 50mg | 59.0mg | +18.0% | 97.12% | Lab B |
| 5 Nov 2025 | Ivermectin | 10.0 | 10mg | 9.9mg | -1.0% | 99.05% | Lab C |
| 5 Nov 2025 | Minoxidil Oral | 9.9 | 100mg | 103.9mg | +3.9% | 95.16% | Lab E |
| 4 Nov 2025 | Clomid | 8.7 | 20mg | 23.2mg | +16.2% | 98.45% | Lab E |
| 4 Nov 2025 | KPV Oral | 9.6 | 20mg | 20.7mg | +3.3% | 97.17% | Lab G |
| 4 Nov 2025 | KPV | 7.3 | 2mg | 2.1mg | +2.5% | 99.45% | Lab D |
| 4 Nov 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 9.2 | 2mg | 2.0mg | +1.5% | 98.86% | Lab D |
| 17 Oct 2025 | Cabergoline | 9.7 | 10mg | 10.9mg | +8.9% | 95.99% | Lab A |
| 17 Oct 2025 | KPV Oral | 9.1 | 100mg | 120.8mg | +20.8% | 96.13% | Lab D |
| 17 Oct 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 7.4 | 5mg | 5.2mg | +4.6% | 97.32% | Lab A |
| 17 Oct 2025 | Testosterone Cypionate Raw | 8.3 | 100g | 91.6g | -8.4% | 95.70% | Lab E |
| 17 Oct 2025 | Thymosin Alpha-1 | 6.9 | 2mg | 1.7mg | -13.3% | 98.71% | Lab G |
| 9 Oct 2025 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 8.3 | 10g | 9.7g | -2.9% | 96.90% | Lab G |
| 9 Oct 2025 | Superdrol | 10.0 | 50mg | 52.0mg | +4.0% | 98.61% | Lab F |
| 9 Oct 2025 | Test Suspension | 10.0 | 200mg/ml | 195.7mg/ml | -2.1% | 96.37% | Lab G |
| 3 Oct 2025 | ARA-290 | 7.4 | 50mg | 57.8mg | +15.5% | 95.20% | Lab F |
| 3 Oct 2025 | HMG | 5.2 | 20mg | 19.7mg | -1.7% | 96.09% | Lab F |
| 3 Oct 2025 | Lipo-C FAT BLASTER | 4.6 | 100mg/ml | 105.7mg/ml | +5.7% | 95.66% | Lab E |
| 3 Oct 2025 | Primobolan Oral (Methenolone Acetate) | 5.7 | 25mg | 21.3mg | -15.0% | 95.94% | Lab G |
| 3 Oct 2025 | Primobolan Oral (Methenolone Acetate) | 8.3 | 100mg | 95.1mg | -4.9% | 98.31% | Lab F |
| 3 Oct 2025 | Testosterone Cypionate Raw | 8.2 | 10g | 9.8g | -1.5% | 96.95% | Lab A |